Product Information
BENAZEPRIL HCL 40 MG TABLET is a generic product labeled by AvPAK, priced at $0.1011 per EA under NDC 50268011215. Its NADAC has been published 464 times since Nov 15, 2017.
FDA first approved this application on Feb 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
AvPAKNDC
50268011215
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076820FDA Approved
2/3/2006
TE Code
AB
On Market Since
4/28/2014
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 40 MG TABLET has been published 464 times since Nov 15, 2017, and over the history we have for it it has risen 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1011 per EA |
|---|---|
| All-time high | $0.1318 (Dec 15, 2021) |
| All-time low | $0.0578 (Jan 23, 2019) |
| 52-week high | $0.1011 |
| 52-week low | $0.0955 |
| Median price | $0.0965 |
| Average price | $0.0927 |
| Largest weekly change | +32.8% (Apr 17, 2019) |
| Weeks tracked | 464 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 40 MG TABLET, manufactured by AvPAK, is $0.1011 per EA (NDC 50268011215), effective Sep 30, 2026.
How has the price of BENAZEPRIL HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 40 MG TABLET has risen 53.6%. It has been tracked across 464 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 40 MG TABLET?
Since Nov 15, 2017, the NADAC for BENAZEPRIL HCL 40 MG TABLET has ranged from a low of $0.0578 (Jan 23, 2019) to a high of $0.1318 (Dec 15, 2021), with a median of $0.0965 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 40 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL HCL 40 MG TABLET?
BENAZEPRIL HCL 40 MG TABLET (NDC 50268011215) is labeled by AvPAK, and CMS classifies it as a generic product.